Saloni Saini
Family · Murrieta, CANPI 1043097041
Payments from drug & device makers
Across 53 payments — averaging $21.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$233
- Collegium Pharmaceutical, Inc.$107
- AbbVie$88
- GSK$85
- Exact Sciences$83
- Lilly USA, LLC$65
- plus $455 from 17 others
What the payments were for
- Food & beverage$1,116100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 11 | $233 |
| Collegium Pharmaceutical, Inc. | 5 | $107 |
| AbbVie | 4 | $88 |
| GSK | 3 | $85 |
| Exact Sciences | 4 | $83 |
| Lilly USA, LLC | 4 | $65 |
| Verity Pharmaceuticals Inc. | 2 | $49 |
| Hologic Sales And Service, LLC | 2 | $40 |
| Pfizer | 2 | $34 |
| Phathom Pharmaceuticals, Inc. | 2 | $33 |
| Boston Scientific | 1 | $33 |
| Inspire Medical Systems, Inc. | 1 | $31 |
| Sumitomo Pharma America, Inc. | 2 | $30 |
| Medtronic | 1 | $30 |
| Evoke Pharma, Inc. | 1 | $25 |
| Edwards Lifesciences | 1 | $24 |
| Amgen | 1 | $23 |
| Optinose US, Inc. | 1 | $22 |
| Tolmar, Inc. | 1 | $20 |
| Phadia US Inc. | 1 | $17 |
| Merck | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| TMS Neurohealth Centers Inc. | 1 | $13 |
How this compares
$1,116 in reported general payments places this provider in the 75th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 26 | $29,412 |
| EntrestoSacubitril/Valsartan | 15 | $9,217 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 11 | $4,888 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 15 | $994 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 18 | $688 |
| Atorvastatin Calcium | 72 | $537 |
| Duloxetine Hcl | 17 | $423 |
| Fluticasone Propionate | 36 | $411 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 22 | $349 |
| Levothyroxine Sodium | 22 | $317 |
| Omeprazole | 26 | $307 |
| Metformin Hcl | 55 | $236 |
| Gabapentin | 22 | $183 |
| Tamsulosin Hcl | 12 | $170 |
| Baclofen | 24 | $166 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKAnoro Ellipta | $85 | $4,88811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 10,634 family providers in California.
Other family in Murrieta
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Nancy GardettoSan Diego$394K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Jenine StoneEscondido$231K
- Erin DwyerSan Diego$189K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.